Information Provided By:
Fly News Breaks for January 18, 2017
INSY
Jan 18, 2017 | 09:39 EDT
Oppenheimer analyst Derek Archila said his recent diligence with a former federal prosecutor leads him to believes that Insys Therapeutics may be nearing a settlement with the DOJ. Resolving the ongoing DOJ investigation would clear the company's major overhang and shares could rally on the announcement, said Archila, though he prefers to stay on the sideline and keeps a Perform rating on the stock, citing the risk he sees to Subsys sales and his belief that consensus Syndros sales estimates are too high.
News For INSY From the Last 2 Days
There are no results for your query INSY